Vizora日本語

COSMOS Pharmaceutical×Sugi Holdings

Different ways of making money, on the same scale.

Same yardstick

MetricCOSMOS PharmaceuticalFY ending May 2026Sugi HoldingsFY ending Feb 2026
Revenue¥1.1T¥1.01T
COGS ratio79.1%68.2%
Operating margin3.9%4.8%
Net margin2.9%4.5%
FCF margin-1.1%6.0%

Highlighted = best value for that metric

Compare industry percentiles by axis

Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.

  • COSMOS PharmaceuticalPrimary industry: Drugstores & Pharmacies
  • Sugi HoldingsPrimary industry: Drugstores & Pharmacies
CompanyRank

  • Revenue growth

    • COSMOS Pharmaceutical53.116 peers
    • Sugi Holdings65.616 peers

  • Profitability

    • COSMOS Pharmaceutical44.719 peers
    • Sugi Holdings65.819 peers

  • Cash conversion

    • COSMOS Pharmaceutical7518 peers
    • Sugi Holdings91.718 peers

  • Efficiency

    • COSMOS Pharmaceutical81.619 peers
    • Sugi Holdings65.819 peers

  • Financial strength

    • COSMOS PharmaceuticalN/A
    • Sugi HoldingsN/A

Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.

Money flows side by side

Chart height is proportional to revenue.

COSMOS Pharmaceutical¥1.1T · keeps ¥4 per ¥100
Sugi Holdings¥1.01T · keeps ¥5 per ¥100

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown